UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-K/A
(AMMENDMENT NO. 1)
(Mark One)
| |
|
|
| þ |
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the
fiscal year ended January 31, 2008
OR
| |
|
|
| o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 0-28132
STREAMLINE HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
31-1455414
(I.R.S. Employer
Identification No.) |
10200 Alliance Road, Suite 200
Cincinnati, OH 45242-4716
(Address of principal executive offices) (Zip Code)
(513) 794-7100
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12 (b) of the Act:
Common Stock, $.01 par value
( Title of Class )
The NASDAQ Stock Market
(Name of exchange on which listed)
Securities registered pursuant to Section 12 (g) of the Act:
None
(continued)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of
the Securities Act. Yes o No þ
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or
Section 15(d) of the Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is
not contained herein, and will not be contained, to the best of the registrant’s knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K,
or any amendment to this Form 10-K. þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large
accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act. (Check one):
| |
|
|
|
|
|
|
| Large accelerated filer
o |
|
Accelerated filer
o |
|
Non-accelerated filer o |
|
Smaller reporting company þ |
| |
|
|
|
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
The aggregate market value of the voting stock held by nonaffiliates of the registrant, computed
using the closing price as reported by The NASDAQ Stock Market, Inc. for the Registrant’s Common
Stock on July 31, 2007, was $20,371,017.
The number of shares outstanding of the Registrant’s Common Stock, $.01 par value, as of April 2,
2008: 9,260,320.
DOCUMENTS INCORPORATED BY REFERENCE
None
EXPALANATORY NOTE
This Amendment No. 1 to the Annual Report on Form 10-K filed by Streamline Health Solutions, Inc.
on April 7, 2008 (the Original Report”) is being filed solely to amend Exhibits 31.1 and 31.2 to
the Original Report and does not affect any other items in the Original Report.